RSS-Feed abonnieren
DOI: 10.1055/s-0029-1217510
A Synthesis-Driven Structure Revision of ‘Plagiochin E’, a Highly Bioactive Bisbibenzyl
Publikationsverlauf
Publikationsdatum:
16. Juni 2009 (online)

Abstract
Recently, a bisbibenzyl named plagiochin E showing remarkable antifungal and antitumor activities was isolated from Marchantia polymorpha, a liverwort. The total synthesis of the proposed structure for plagiochin E and of two structurally and biosynthetically related bisbibenzyls and comparison of the NMR data of the synthetic compounds with those of the isolated bisbibenzyls necessitates a structure revision for plagiochin E. Exemplarily for this metabolite, the stereostructure was investigated, by racemate resolution on a chiral Lux Cellulose-1 phase with HPLC-CD coupling and quantum chemical CD calculations, clearly assigning the P-configuration for the faster and the M-configuration to the slower enantiomer.
Key words
plagiochin E - bisbibenzyl - axially chiral biaryl - total synthesis - natural products - circular dichroism
- 1
Asakawa Y. In Progress in the Chemistry of Organic Natural ProductsHerz E.Kirby GW.Moore RE.Steglich W.Tamm C. Springer; Vienna/New York: 1995. p.5 - 2
Keserü GM.Nógrádi M. Phytochemistry 1992, 31: 1573 - 3
Asakawa Y.Toyota M.Tori M.Hashimoto T. Spectroscopy 2000, 14: 149 - 4
Eicher T.Fey S.Puhl W.Büchel E.Speicher A. Eur. J. Org. Chem. 1998, 877 - 5
Speicher A.Backes T.Grosse S. Tetrahedron 2005, 61: 11692 - 6
Speicher A.Kolz J.Sambanje RP. Synthesis 2002, 2503 - 7
Bringmann G.Mühlbacher J.Reichert M.Dreyer M.Kolz J.Speicher A. J. Am. Chem. Soc. 2004, 126: 9283 - 8
Scher JM.Zapp J.Becker H.Kather N.Kolz J.Speicher A.Dreyer M.Maksimenka K.Bringmann G. Tetrahedron 2004, 60: 9877 - 9
Hashimoto T.Tori M.Asakawa Y.Fukazawa Y. Tetrahedron Lett. 1987, 28: 6295 - 10
Keseru GM.Mezey-Vándor G.Nógrádi M.Vermes B.Kajtár-Peredy M. Tetrahedron 1992, 48: 913 - 11
Fukuyama Y.Yaso H.Nakamura K.Kodama M. Tetrahedron Lett. 1999, 40: 105 - 12
Fukuyama Y.Yaso H.Mori T.Takahashi H.Minami H.Kodama M. Heterocycles 2001, 54: 259 - 13
Niu C.Qu JB.Lou HX. Chem. Biodiversity 2006, 3: 34 - 14
Qu J.Xie C.Guo H.Yu W.Lou H. Phytochemistry 2007, 68: 1767 - 15
Wu XZ.Cheng AX.Sun LM.Lou HX. Acta Pharmacol. Sin. 2008, 29: 1478 - 16
Sun LM.Lv BB.Cheng AX.Wu XZ.Lou HX. Biol. Pharm. Bull. 2009, 32: 36 - 17
Shi YQ.Qu XJ.Liao YX.Xie CF.Cheng YN.Li S.Lou HX. Eur. J. Pharmacol. 2008, 584: 66 - 18
Xing J.Lv B.Xie C.Qu J.Lou H. J. Pharm. Biomed. Anal. 2008, 47: 949 - 19
Asakawa Y.Ludwiczuk A.Nagashima F.Toyota M.Hashimoto T.Tori M.Fukuyama Y.Harinantenaina L. Heterocycles 2009, 77: 99 - 20
Harrowven DC.Woodcock TH.Peter D. Angew. Chem. Int. Ed. 2005, 44: 3967 - 21
Speicher A. J. Prakt. Chem. 2000, 342: 162 - 22
Rosillo M.Dominguez G.Casarrubios L.Amador U.Prez-Castells J. J. Org. Chem. 2004, 69: 2084 - 24
Toyota M.Nagashima F.Asakawa J. Phytochemistry 1988, 27: 2603 - 25
Asakawa Y.Tori M.Takikawa K.Krishnamurty HG.Kanti Kar S. Phytochemistry 1987, 26: 1811 - 27
Bringmann G.Gulder TAM.Reichert M.Gulder T. Chirality 2008, 20: 628 -
28a
Frisch MJ.Trucks GW.Schlegel HB.Scuseria GE.Robb MA.Cheeseman JR.Montgomery JA.Vreven T.Kudin KN.Burant JC.Millam JM.Iyengar SS.Tomasi J.Barone V.Mennucci B.Cossi M.Scalmani G.Rega N.Petersson GA.Nakatsuji H.Hada M.Ehara M.Toyota K.Fukuda R.Hasegawa J.Is hida M.Nakajima T.Honda Y.Kitao O.Nakai H.Klene M.Li X.Knox JE.Hratchian HP.Cross JB.Bakken V.Adamo C.Jaramillo J.Gomperts R.Stratmann RE.Yazyev O.Austin AJ.Cammi R.Pomelli C.Ochterski JW.Ayala PY.Morokuma K.Voth GA.Salvador P.Dannenberg JJ.Zakrzewski VG.Dapprich S.Daniels AD.Strain MC.Farkas O.Malick DK.Rabuck AD.Raghavachari K.Foresman JB.Ortiz JV.Cui Q.Baboul AG.Clifford S.Cioslowski J.Stefanov BB.Liu G.Liashenko A.Piskorz P.Komaromi I.Martin RL.Fox DJ.Keith T.Al-Laham MA.Peng CY.Nanayakkara A.Challacombe M.Gill PMW.Johnson B.Chen W.Wong MW.Gonzalez C.Pople JA. Gaussian 03, Revision D.01 Gaussian Inc.; Wallingford CT: 2004. -
28b
Neese F. ORCA, An ab initio, Density Functional, and Semi-Empirical Program Package, Version 2.6.35 Universität Bonn; Germany: 2008. -
28c
Details of the quantum chemical calculations will be published in a comprehensive paper, including details about the use of the method in comparison to other computational procedures.
- 29
Bringmann G.Bruhn T.Maksimenka K.Hemberger Y. Eur. J. Org. Chem. 2009, 2717
References and Notes
General Procedure for the McMurry Macrocyclization: A mixture of zinc dust (2.12 g, 32.4 mmol) and TiCl3(DME)2 (3.00 g, 8.76 mmol) in anhyd DME (80 mL) was heated to reflux for 1.5 h under an argon atmosphere. A solution of the dialdehyde (560 mg, 1.13 mmol) in anhyd DME (100 mL) was added dropwise over 5 h. The black mixture was heated to reflux for 48 h. After cooling to r.t. the reaction mixture was filtered through a short pad of silica gel eluting with EtOAc. The colorless filtrate was then concentrated and purified by flash chromatography (silica gel; hexane-EtOAc, 3:1).
26Resolution of the enantiomers of 4 was carried out on a Lux Cellulose-1 phase (4.6 mm × 250 mm, 5 µm, Phenomenex); flow rate: 0.5 mL/min using an i-PrOH-n-hexane gradient (20:80, 60:40 for 16.5 min, 95:5 for 9.5 min, 20:80 for 2 min, 20:80 for 12 min).
30A solution of 37 (2.50 g, 5.03 mmol) and Ph3P˙HBr (1.81 g, 5.27 mmol) in MeCN (60 mL) was refluxed for 12 h. The solvent was removed in vacuo and the crude phosphonium salt was dissolved in anhyd CH2Cl2 (250 mL). This solution was added dropwise over 6 h to a mixture of NaOMe (1.50 g, 27.8 mmol) in anhyd CH2Cl2 (350 mL), and stirring was continued for 12 h. After filtration and evaporation of the solvent the residue was purified by column chromatography (silica gel, CH2Cl2) and 38 was obtained as a colorless solid (1.60 g, 3.44 mmol, 68%).